Flower City Capital, a registered investment adviser based in Pittsford, New York, has filed a Form 13F-HR with the U.S. Securities and Exchange Commission disclosing its equity portfolio holdings as of September 30, 2026. The filing, signed by Chief Compliance Officer Vincent Crane, lists 44 separate securities held by the firm.
The portfolio is dominated by exchange-traded funds (ETFs), with several Vanguard funds comprising the largest positions. The largest holding is the Vanguard International Equity Index Fund FTSE All-World ex US, which comprises 852,358 shares. Other significant ETF positions include the Vanguard International Equity Index Fund FTSE Developed Markets ETF (430,473 shares) and the Vanguard International Equity Index Fund Total World Stock ETF (4,405 shares).
Within the firm's individual stock holdings, Kura Oncology Inc. is listed with a position of 23,000 shares, followed by Outlook Therapeutics Inc. with 50,000 shares and Precigen Inc. with 20,000 shares. Other notable individual stock positions include Alphabet Inc. Class A (1,731 shares), Amazon.com Inc. (4,186 shares), Apple Inc. (13,989 shares), Microsoft Corporation (3,041 shares), and NVIDIA Corporation (7,425 shares).
The filing also lists positions in various other companies, including Berkshire Hathaway Inc., Chevron Corporation, Home Depot Inc., and JPMorgan Chase & Co. Additionally, the firm holds shares in the Schwab Strategic Trust Emerging Markets Equity ETF, the Schwab Strategic Trust US Large Cap ETF, and the Schwab Strategic Trust US Small Cap ETF.
